Innovation Pharmaceuticals Inc (IPIX)

[livefree_ordie]

A couple of reminders here for longs and newcomers to IPIX Know what we own folks. Do not lose faith by any negative posters here. Its all good. Gee why would the Government want to check how Brilacidin will perform against these others virus’s?? Things that make you go hmmmmm…………………….. But we know why don’t we folks. Good night all.
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

The Company is also pleased to report Brilacidin has been shipped to two academic laboratories for planned in vitro testing of Brilacidin in over 20 acutely infectious viruses, including Ebola, Marburg, Nipah, West Nile and Zika, through a collaboration with U.S. government scientists. The goal of this testing is to further inform the spectrum of Brilacidin’s antiviral properties.
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

Today the Company announced and anticipates reporting topline results the week of November 8th from its Phase 2 clinical trial of Brilacidin for treatment of moderate-to-severe COVID-19 in hospitalized patients

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++


Dr Degrado, IPIX science advisor, is acknowledged by his peers as a leading researcher in the field of proteins, peptides
and defensins as well as defensin based pharmaceuticals.

Brilacidin is based structurally on a defensin peptide, Magainin. Attempts to make Magainin a therapeutic failed to to the structural weakness in its peptide core.

Dr Degrado and his team used biochemical and supercomputer enhancement to produce a new pharmacologically stable compound with superior antibiotic, anti-inflammatory and now antiviral capabilities, Brilacidin.

Having Dr DeGrado give a portion of a named lecture in his field is an honor .

Having Dr Degrado as IPIX's scientific advisor gives IPIX and Brilacidin scientific and academic credibility that is priceless.

Brilacidin research is just beginning to open its multiple possible uses as a pharmacologic agent.